As company struggles, Novo Nordisk CEO Jørgensen to step down
Andrew Joseph , 2025-05-16 11:35:00 Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — Lars Fruergaard Jørgensen, who led Novo Nordisk as it rode the boom of its obesity and diabetes medications to become one of the biggest players in pharma, only to…